Author

S.-A. Azizi

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:proteomics· 2 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Research Focus:metabolism & bioenergetics· 1 Organism:mouse· 1

Frequent Co-Authors

B. C. Dickinson· 2 shared A. Jaochimiak· 1 shared B. C. Mounce· 1 shared B. Schuster· 1 shared C. B. Brooke· 1 shared E. A. Bruce· 1 shared G. Randall· 1 shared H. M. Froggatt· 1 shared

Activity by Year

2020-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBiochemistry

B. C. Dickinson

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Regulation of ERK2 activity by dynamic S-acylation

S.-A. Azizi, T. Qiu, N. Brookes, B. C. Dickinson

This study identifies S-acylation as a regulatory mechanism for ERK1/2 activity, showing its modulation by EGF signaling and its impact on transcriptional programs and metabolic health.

bioRxiv · Nov 5, 2021Biochemistry

Drug repurposing screen identifies masitinib as a 3CLpro inhibitor that blocks replication of SARS-CoV-2 in vitro

N. Drayman, K. A. Jones, S.-A. Azizi, H. M. Froggatt, K. Tan, N. Ivanova Maltseva, S. Chen, V. Nicolaescu, S. Dvorkin, K. Furlong, R. S. Kathayat, M. R. Firpo, V. Mastrodomenico, E. A. Bruce, M. M. Schmidt, , S. Tay

The paper screens 1,900 drugs to find inhibitors of SARS-CoV-2 replication, identifies masitinib as a 3CLpro inhibitor effective in vitro, and shows its broad anti-viral activity.

bioRxiv · Aug 31, 2020Microbiology